Inflazome

Developer of inhibitors for the treatment of chronic inflammatory diseases

placeDublin, Leinster, Ireland calendar_todayFounded 2016 groups2 employees language inflazome.com

Registered entities

Innovation

103 patent families (19 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 6,550 times.

YearFilings
201712
201825
201947
202037
202132
202219
20238
202410
20254

Investor mix

5 investors on record; lead investors include Forbion, Novartis Venture Fund, Fountain Healthcare Partners; 1 has since exited.

Investor typeCountShare
Venture capital360%
Private equity120%
Other / undisclosed120%
Coming soon